The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Aoife.Williamson@glasgow.ac.uk
RA010. Level 0,, Beatson WOSCC, 1052 Great Western Road, Glasgow, G12 0YN
Williamson, A., Houston, P., Paterson, J., Chalmers, A. J. , McLoone, P. , Fullerton, N., Foo, S. Y., James, A. and Nowicki, S. (2024) Dosimetric comparison of hippocampal sparing technologies in patients with low grade glioma. Neuro-Oncology Advances, (doi: 10.1093/noajnl/vdae131) (Early Online Publication)
Lorimer, C., Mills, S., Chalmers, A. , Coombes, I., Thompson, G., Glendenning, J., Radon, M., Jones, C., Williamson, A. and Brock, J. (2024) Baseline total brain volume predicts changes in quality of life and overall survival after cranial radiotherapy in older patients with glioblastoma: Results from the prospective BRITER study. Neuro-Oncology Practice, 11(4), pp. 413-420. (doi: 10.1093/nop/npae019) (PMID:39006523)
Derby, S. et al. (2024) Concurrent olaparib and radiotherapy in elderly patients with newly diagnosed glioblastoma: the phase I dose escalation PARADIGM trial. International Journal of Radiation Oncology, Biology, Physics, 118(5), pp. 1371-1378. (doi: 10.1016/j.ijrobp.2024.01.011) (PMID:38211641)
Boele, F. et al. (2024) Inequalities in access to neuro-oncology supportive care and rehabilitation: a survey of healthcare professionals’ perspectives. Neuro-Oncology Practice, (doi: 10.1093/nop/npae023) (Early Online Publication)
Williamson, A., Houston, P., Paterson, J., Chalmers, A. J. , McLoone, P. , Fullerton, N., Foo, S. Y., James, A. and Nowicki, S. (2024) Dosimetric comparison of hippocampal sparing technologies in patients with low grade glioma. Neuro-Oncology Advances, (doi: 10.1093/noajnl/vdae131) (Early Online Publication)
Lorimer, C., Mills, S., Chalmers, A. , Coombes, I., Thompson, G., Glendenning, J., Radon, M., Jones, C., Williamson, A. and Brock, J. (2024) Baseline total brain volume predicts changes in quality of life and overall survival after cranial radiotherapy in older patients with glioblastoma: Results from the prospective BRITER study. Neuro-Oncology Practice, 11(4), pp. 413-420. (doi: 10.1093/nop/npae019) (PMID:39006523)
Derby, S. et al. (2024) Concurrent olaparib and radiotherapy in elderly patients with newly diagnosed glioblastoma: the phase I dose escalation PARADIGM trial. International Journal of Radiation Oncology, Biology, Physics, 118(5), pp. 1371-1378. (doi: 10.1016/j.ijrobp.2024.01.011) (PMID:38211641)
Boele, F. et al. (2024) Inequalities in access to neuro-oncology supportive care and rehabilitation: a survey of healthcare professionals’ perspectives. Neuro-Oncology Practice, (doi: 10.1093/nop/npae023) (Early Online Publication)